Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Two decades of the impact of Tasmanian Devil Facial Tumour Disease (DFTD).

Woods GM, Fox S, Flies AS, Tovar CD, Jones M, Hamede R, Pemberton D, Lyons AB, Bettiol SS.

Integr Comp Biol. 2018 Sep 25. doi: 10.1093/icb/icy118. [Epub ahead of print]

PMID:
30252058
2.

Electrophysiological assessment methodology of sensory processing dysfunction in schizophrenia and dementia of the Alzheimer type.

Danjou P, Viardot G, Maurice D, Garcés P, Wams EJ, Phillips KG, Bertaina-Anglade V, McCarthy AP, Pemberton DJ.

Neurosci Biobehav Rev. 2018 Sep 6. pii: S0149-7634(17)30864-3. doi: 10.1016/j.neubiorev.2018.09.004. [Epub ahead of print] Review.

PMID:
30195932
3.

Density trends and demographic signals uncover the long-term impact of transmissible cancer in Tasmanian devils.

Lazenby BT, Tobler MW, Brown WE, Hawkins CE, Hocking GJ, Hume F, Huxtable S, Iles P, Jones ME, Lawrence C, Thalmann S, Wise P, Williams H, Fox S, Pemberton D.

J Appl Ecol. 2018 May;55(3):1368-1379. doi: 10.1111/1365-2664.13088. Epub 2018 Feb 5.

4.

Mass spectrometric characterization of intact desferal-conjugated monoclonal antibodies for immuno-PET imaging.

De Vijlder T, Fissers J, Van Broeck B, Wyffels L, Mercken M, Pemberton DJ.

Rapid Commun Mass Spectrom. 2018 Jun 26. doi: 10.1002/rcm.8209. [Epub ahead of print]

PMID:
29943865
5.

S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.

Leinonen V, Rauramaa T, Johansson J, Bottelbergs A, Tesseur I, van der Ark P, Pemberton D, Koivisto AM, Jääskeläinen JE, Hiltunen M, Herukka SK, Blennow K, Zetterberg H, Jokinen P, Rokka J, Helin S, Haaparanta-Solin M, Solin O, Okamura N, Kolb HC, Rinne JO.

J Alzheimers Dis. 2018;64(1):171-179. doi: 10.3233/JAD-180071.

PMID:
29865068
6.

Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers.

Postnov A, Schmidt ME, Pemberton DJ, de Hoon J, van Hecken A, van den Boer M, Zannikos P, van der Ark P, Palmer JA, Rassnick S, Celen S, Bormans G, van Laere K.

Clin Transl Sci. 2018 Jul;11(4):397-404. doi: 10.1111/cts.12548. Epub 2018 Mar 25.

7.

Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release.

Pye R, Patchett A, McLennan E, Thomson R, Carver S, Fox S, Pemberton D, Kreiss A, Baz Morelli A, Silva A, Pearse MJ, Corcoran LM, Belov K, Hogg CJ, Woods GM, Lyons AB.

Front Immunol. 2018 Feb 19;9:259. doi: 10.3389/fimmu.2018.00259. eCollection 2018.

8.

Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathology.

Praet J, Manyakov NV, Muchene L, Mai Z, Terzopoulos V, de Backer S, Torremans A, Guns PJ, Van De Casteele T, Bottelbergs A, Van Broeck B, Sijbers J, Smeets D, Shkedy Z, Bijnens L, Pemberton DJ, Schmidt ME, Van der Linden A, Verhoye M.

Alzheimers Res Ther. 2018 Jan 9;10(1):1. doi: 10.1186/s13195-017-0329-8.

9.

Increasing generations in captivity is associated with increased vulnerability of Tasmanian devils to vehicle strike following release to the wild.

Grueber CE, Reid-Wainscoat EE, Fox S, Belov K, Shier DM, Hogg CJ, Pemberton D.

Sci Rep. 2017 May 19;7(1):2161. doi: 10.1038/s41598-017-02273-3.

10.

Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii).

Ujvari B, Hamede R, Peck S, Pemberton D, Jones M, Belov K, Madsen T.

Sci Rep. 2016 Apr 29;6:25093. doi: 10.1038/srep25093.

11.

In Vivo Amyloid-β Imaging in the APPPS1-21 Transgenic Mouse Model with a (89)Zr-Labeled Monoclonal Antibody.

Waldron AM, Fissers J, Van Eetveldt A, Van Broeck B, Mercken M, Pemberton DJ, Van Der Veken P, Augustyns K, Joossens J, Stroobants S, Dedeurwaerdere S, Wyffels L, Staelens S.

Front Aging Neurosci. 2016 Mar 31;8:67. doi: 10.3389/fnagi.2016.00067. eCollection 2016.

12.

Synthesis and Evaluation of a Zr-89-Labeled Monoclonal Antibody for Immuno-PET Imaging of Amyloid-β Deposition in the Brain.

Fissers J, Waldron AM, De Vijlder T, Van Broeck B, Pemberton DJ, Mercken M, Van Der Veken P, Joossens J, Augustyns K, Dedeurwaerdere S, Stroobants S, Staelens S, Wyffels L.

Mol Imaging Biol. 2016 Aug;18(4):598-605. doi: 10.1007/s11307-016-0935-z.

PMID:
26846128
13.

A second transmissible cancer in Tasmanian devils.

Pye RJ, Pemberton D, Tovar C, Tubio JM, Dun KA, Fox S, Darby J, Hayes D, Knowles GW, Kreiss A, Siddle HV, Swift K, Lyons AB, Murchison EP, Woods GM.

Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):374-9. doi: 10.1073/pnas.1519691113. Epub 2015 Dec 28.

14.

The Tasmanian devil microbiome-implications for conservation and management.

Cheng Y, Fox S, Pemberton D, Hogg C, Papenfuss AT, Belov K.

Microbiome. 2015 Dec 21;3:76. doi: 10.1186/s40168-015-0143-0.

15.

Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans.

Deguil J, Ravasi L, Auffret A, Babiloni C, Bartres Faz D, Bragulat V, Cassé-Perrot C, Colavito V, Herrero Ezquerro MT, Lamberty Y, Lanteaume L, Pemberton D, Pifferi F, Richardson JC, Schenker E, Blin O, Tarragon E, Bordet R.

Drug Discov Today Technol. 2013 Sep;10(3):e329-42. Review.

PMID:
24179995
16.

Early results with a patient specific interpositional knee device.

Brooks F, Akram T, Roy S, Pemberton D, Chandatreya A.

Acta Orthop Belg. 2012 Aug;78(4):500-5.

PMID:
23019783
17.

The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2-yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancement.

Skidmore J, Atcha Z, Boucherat E, Castelletti L, Chen DW, Coppo FT, Cutler L, Dunsdon RM, Heath BM, Hutchings R, Hurst DN, Javed S, Martin S, Maskell ES, Norton D, Pemberton DJ, Redshaw S, Rutter R, Sehmi SS, Scoccitti T, Temple HE, Theobald P, Ward RW, Wilson DM.

Bioorg Med Chem Lett. 2012 May 15;22(10):3531-4. doi: 10.1016/j.bmcl.2012.03.062. Epub 2012 Mar 21.

PMID:
22503453
18.

Identification of a series of 1,3,4-oxadiazol-2-amines as potent alpha-7 agonists with efficacy in the novel object recognition model of cognition.

Skidmore J, Atcha Z, Boucherat E, Castelletti L, Chen DW, Coppo FT, Cutler L, Dunsdon RM, Heath BM, Hutchings R, Hurst DN, Javed S, Martin S, Maskell ES, Norton D, Pemberton DJ, Redshaw S, Rutter R, Sehmi SS, Scoccitti T, Temple HE, Theobald P, Ward RW, Wilson DM.

Bioorg Med Chem Lett. 2012 May 15;22(10):3560-3. doi: 10.1016/j.bmcl.2012.03.040. Epub 2012 Mar 16.

PMID:
22503248
19.

PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats.

McLean SL, Idris NF, Grayson B, Gendle DF, Mackie C, Lesage AS, Pemberton DJ, Neill JC.

J Psychopharmacol. 2012 Sep;26(9):1265-70. doi: 10.1177/0269881111431747. Epub 2011 Dec 18.

PMID:
22182741
20.

Synaptic transmission changes in fear memory circuits underlie key features of an animal model of schizophrenia.

Pollard M, Varin C, Hrupka B, Pemberton DJ, Steckler T, Shaban H.

Behav Brain Res. 2012 Feb 1;227(1):184-93. doi: 10.1016/j.bbr.2011.10.050. Epub 2011 Nov 9.

PMID:
22085880
21.

Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist.

Dedeurwaerdere S, Wintmolders C, Straetemans R, Pemberton D, Langlois X.

Psychopharmacology (Berl). 2011 Mar;214(2):505-14. doi: 10.1007/s00213-010-2052-z. Epub 2010 Oct 31.

PMID:
21057775
22.

Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.

McLean SL, Grayson B, Idris NF, Lesage AS, Pemberton DJ, Mackie C, Neill JC.

Eur Neuropsychopharmacol. 2011 Apr;21(4):333-43. doi: 10.1016/j.euroneuro.2010.06.003. Epub 2010 Jul 13.

PMID:
20630711
23.

Alternative method of oral dosing for rats.

Atcha Z, Rourke C, Neo AH, Goh CW, Lim JS, Aw CC, Browne ER, Pemberton DJ.

J Am Assoc Lab Anim Sci. 2010 May;49(3):335-43.

24.

Rasagiline improves learning and memory in young healthy rats.

Wong FK, Lee SH, Atcha Z, Ong AB, Pemberton DJ, Chen WS.

Behav Pharmacol. 2010 Jul;21(4):278-82. doi: 10.1097/FBP.0b013e32833aec02.

PMID:
20520531
25.

Effect of donepezil on reversal learning in a touch screen-based operant task.

Chen WS, Wong FK, Chapman PF, Pemberton DJ.

Behav Pharmacol. 2009 Oct;20(7):653-6. doi: 10.1097/FBP.0b013e32832ec5bc.

PMID:
19654507
26.

Cognitive enhancing effects of ghrelin receptor agonists.

Atcha Z, Chen WS, Ong AB, Wong FK, Neo A, Browne ER, Witherington J, Pemberton DJ.

Psychopharmacology (Berl). 2009 Oct;206(3):415-27. doi: 10.1007/s00213-009-1620-6. Epub 2009 Aug 4.

PMID:
19652956
27.

Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat.

Woolley ML, Waters KA, Gartlon JE, Lacroix LP, Jennings C, Shaughnessy F, Ong A, Pemberton DJ, Harries MH, Southam E, Jones DN, Dawson LA.

Psychopharmacology (Berl). 2009 Jan;202(1-3):343-54. doi: 10.1007/s00213-008-1325-2. Epub 2008 Sep 16.

PMID:
18795266
28.

Life-history change in disease-ravaged Tasmanian devil populations.

Jones ME, Cockburn A, Hamede R, Hawkins C, Hesterman H, Lachish S, Mann D, McCallum H, Pemberton D.

Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10023-7. doi: 10.1073/pnas.0711236105. Epub 2008 Jul 14.

29.

The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity.

Woolley ML, Pemberton DJ, Bate S, Corti C, Jones DN.

Psychopharmacology (Berl). 2008 Feb;196(3):431-40. Epub 2007 Dec 5.

PMID:
18057917
30.

In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia.

Dawson LA, Cato KJ, Scott C, Watson JM, Wood MD, Foxton R, de la Flor R, Jones GA, Kew JN, Cluderay JE, Southam E, Murkitt GS, Gartlon J, Pemberton DJ, Jones DN, Davies CH, Hagan J.

Neuropsychopharmacology. 2008 Jun;33(7):1642-52. Epub 2007 Aug 29.

31.

Genetic screening for prey in the gut contents from a giant squid (Architeuthis sp.).

Deagle BE, Jarman SN, Pemberton D, Gales NJ.

J Hered. 2005 Jul-Aug;96(4):417-23. Epub 2005 Mar 2.

PMID:
15743905
32.

Hydrolytic stability of toluene diisocyanate and polymeric methylenediphenyl diisocyanate based polyureas under environmental conditions.

Sendijarevic V, Sendijarevic A, Sendijarevic I, Bailey RE, Pemberton D, Reimann KA.

Environ Sci Technol. 2004 Feb 15;38(4):1066-72.

PMID:
14998020
33.
34.

Ionic basis of the resting membrane potential and action potential in the pharyngeal muscle of Caenorhabditis elegans.

Franks CJ, Pemberton D, Vinogradova I, Cook A, Walker RJ, Holden-Dye L.

J Neurophysiol. 2002 Feb;87(2):954-61.

36.

Beware of groin pain in the elderly athlete.

Williams EV, Hughes JL, Pemberton D, Foster ME.

Hosp Med. 2001 Jan;62(1):52-3. No abstract available.

PMID:
11211464
37.

Physiological and pharmacological studies on nematodes.

Walker RJ, Franks CJ, Pemberton D, Rogers C, Holden-Dye L.

Acta Biol Hung. 2000;51(2-4):379-94.

PMID:
11034163
38.

Radial stress fracture adjacent to a metal plate following weight training.

Evans NA, Pemberton DJ.

Injury. 1998 Jan;29(1):79-80. No abstract available.

PMID:
9659489
39.
40.

Polyol-combinant saliva stimulants and oral health in Veterans Affairs patients--an exploratory study.

Mäkinen KK, Pemberton D, Mäkinen PL, Chen CY, Cole J, Hujoel PP, Lopatin D, Lambert P.

Spec Care Dentist. 1996 May-Jun;16(3):104-15.

41.

Saliva stimulants and the oral health of geriatric patients.

Mäkinen KK, Pemberton D, Cole J, Mäkinen PL, Chen CY, Lambert P.

Adv Dent Res. 1995 Jul;9(2):125-6.

PMID:
7546130
42.

Fractures of the distal femur in the elderly treated with a carbon fibre supracondylar plate.

Pemberton DJ, Evans PD, Grant A, McKibbin B.

Injury. 1994 Jul;25(5):317-21.

PMID:
8034351
43.

The structure of the insertions of the tendons of biceps brachii, triceps and brachialis in elderly dissecting room cadavers.

Benjamin M, Newell RL, Evans EJ, Ralphs JR, Pemberton DJ.

J Anat. 1992 Apr;180 ( Pt 2):327-32.

44.

Carbon-fibre reinforced plates for problem fractures.

Pemberton DJ, McKibbin B, Savage R, Tayton K, Stuart D.

J Bone Joint Surg Br. 1992 Jan;74(1):88-92.

PMID:
1732273
45.

Quantitative differences in the histology of the attachment zones of the meniscal horns in the knee joint of man.

Benjamin M, Evans EJ, Rao RD, Findlay JA, Pemberton DJ.

J Anat. 1991 Aug;177:127-34.

46.
47.

Muscle biopsy proven malignant hyperpyrexia and minimal symptoms under inhalational anaesthesia.

Pemberton DM.

Anaesth Intensive Care. 1991 Feb;19(1):133-4. No abstract available.

PMID:
2012285
48.

Arthroscopic use of the Herbert screw in osteochondritis dissecans.

Mackie IG, Pemberton DJ, Maheson M.

J Bone Joint Surg Br. 1990 Nov;72(6):1076. No abstract available.

PMID:
2246293
49.

A new surgical drainage procedure for Baker's cysts.

Pemberton DJ, Mackie IG, Maheson M.

Ann R Coll Surg Engl. 1990 Nov;72(6):373-4. No abstract available.

50.

Synergism within polyhexamethylene biguanide biocide formulations.

Gilbert P, Pemberton D, Wilkinson DE.

J Appl Bacteriol. 1990 Oct;69(4):593-8.

PMID:
2292523

Supplemental Content

Loading ...
Support Center